Bridgewater Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $364K | Sell |
4,236
-697
| -14% | -$59.8K | 0.03% | 309 |
|
|
2025
Q1 | $404K | Buy |
+4,933
| New | +$404K | 0.04% | 268 |
|
|
2022
Q3 | – | Sell |
-8,937
| Closed | -$664K | – | 229 |
|
|
2022
Q2 | $664K | Hold |
8,937
| – | – | 0.14% | 117 |
|
|
2022
Q1 | $803K | Hold |
8,937
| – | – | 0.2% | 101 |
|
|
2021
Q4 | $1M | Hold |
8,937
| – | – | 0.22% | 97 |
|
|
2021
Q3 | $1.12M | Sell |
8,937
-350
| -4% | -$44K | 0.31% | 76 |
|
|
2021
Q2 | $1.26M | Buy |
9,287
+899
| +11% | +$122K | 0.4% | 68 |
|
|
2021
Q1 | $1.04M | Buy |
+8,388
| New | +$1.04M | 0.53% | 54 |
|
|
2014
Q2 | $1.79M | Buy |
+34,932
| New | +$1.79M | 1.5% | 23 |
|